Meeting
2016 ASCO Annual Meeting
Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer (LC): implications for immunotherapy.
Authors
David James Pinato
Department of Surgery & Cancer, Imperial College London, London, United Kingdom
David James Pinato , Robert J Shiner , Solomon D T White , James M Black , Pritesh Trivedi , Justin Stebbing , Rohini Sharma , Francesco A Mauri
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Tumor Biology
Track
Tumor Biology
Sub Track
Tumor-Based Biomarkers
Citation
J Clin Oncol 34, 2016 (suppl; abstr 11601)
DOI
10.1200/JCO.2016.34.15_suppl.11601
Abstract #
11601
Poster Bd #
298
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Pan-cancer landscape of CD274 (PD-L1) and PDCD1LG2 (PD-L2) structural variations.
First Author: Emily Louise Hoskins
Poster
2021 ASCO Annual Meeting
Stereotactic body radiation therapy and in situ oncolytic virus therapy followed by immunotherapy in metastatic non-small cell lung cancer.
First Author: Carlo Guerrero
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Therapeutic checkpoint targets: Evaluation of co-expression profiles in individual tumor and immune cells in the tumor microenvironment of FFPE tissue.
First Author: Annelies Laeremans
Poster
2023 ASCO Annual Meeting
Exploring the potential of combination immune checkpoint strategies in non-small cell lung cancer (NSCLC).
First Author: Aakash Desai